Literature DB >> 6537898

Curability of mouse L1210 leukemia by combination of 5-fluorouracil, cis-diamminedichloroplatinum(II), and low doses of gamma-rays.

C Dionet, P Verrelle.   

Abstract

By combining 5-fluorouracil and cis-diamminedichloro-platinum(II) at drug levels which are ineffective when used alone, we have cured L1210 leukemia in mice in a single treatment session. It was also discovered that the doses of the drugs used in this combination can be decreased, with no corresponding decrease in their effectiveness, if they are administered in conjunction with a very low dose of radiation (gamma-rays), which, when used alone, is ineffective. In the cells, the explanation for the synergic action of radiation, 5-fluorouracil, and cis-diamminedichloroplatinum(II) can be found in the action of each of the cytostatics at different phases of the cell cycle, each cytostatic favoring the action of the others. It is important to emphasize the order in which chemotherapy and radiotherapy are administered, as well as the time lapse between administration of the two treatments, maximum effectiveness having been obtained when radiotherapy was carried out 8 to 24 hr after chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6537898

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Clinical pharmacokinetics of 3-day continuous infusion cisplatin and daily bolus 5-fluorouracil.

Authors:  J F Belliveau; M R Posner; G W Crabtree; A B Weitberg; M C Wiemann; F J Cummings; G P O'Leary; E Ingersoll; P Calabresi
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Chemoradiotherapy: the new standard care for invasive cervical cancer.

Authors:  P G Rose
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

3.  Cytocidal and toxic effect of various cytostatic drugs on three ascites tumors of the mouse.

Authors:  E Schäfer; B Maurer-Schultze
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

4.  The efficacy of concurrent cisplatin and 5-flurouracil chemotherapy and radiation therapy for locally advanced cancer of the uterine cervix.

Authors:  Il Jung Choi; Moon Seok Cha; Eunku Seul Park; Myung Seok Han; Youngmin Choi; Goo Hwa Je; Hyun Ho Kim
Journal:  J Gynecol Oncol       Date:  2008-06-20       Impact factor: 4.401

5.  Srinagarind Hospital experience in concurrent chemoradiation for 100 patients with stage IB2 to IVA uterine cervical cancer.

Authors:  Thumwadee Tangsiriwatthana; Bandit Chumworathayi; Pissamai Yuenyao; Sanguanchoke Luanratanakorn; Jeerichuda Pattamadilok
Journal:  Radiat Med       Date:  2007-12-25

6.  Dose reduction without loss of efficacy for 5-fluorouracil and cisplatin combined with folinic acid. In vitro study on human head and neck carcinoma cell lines.

Authors:  M C Etienne; S Bernard; J L Fischel; P Formento; J Gioanni; J Santini; F Demard; M Schneider; G Milano
Journal:  Br J Cancer       Date:  1991-03       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.